Literature DB >> 22634309

EBF1 acts as a powerful repressor of Blimp-1 gene expression in immature B cells.

Hidehiko Kikuchi1, Masami Nakayama, Yasunari Takami, Futoshi Kuribayashi, Tatsuo Nakayama.   

Abstract

The transcription factor, early B cell factor 1 (EBF1) with an atypical zinc-finger and helix-loop-helix motif, is essential for development and differentiation of lymphocytes. In mice, EBF1 is involved in the generation of pre-pro B cells (the first specified progenitors of B cells) from common lymphoid progenitors (CLPs) and transcription regulations of various genes involved in B cell-development, for instance, mb-1 and Pax5. During B lymphopoiesis, interestingly, EBF1 is detected throughout from CLPs to mature B cells. However, in immature B cells, the physiological role of EBF1 remains to be elucidated. Here, by analyzing EBF1-deficient DT40 cells, EBF1(-/-), generated by us, we show that EBF1-deficiency caused significant increases (to ∼800%) in both mRNA and protein levels of B lymphocyte-induced maturation protein-1 (Blimp-1), the master gene for plasma cell differentiation. In addition, both transcription and protein synthesis of Blimp-1 were remarkably down-regulated (to ∼20%) by re-expression (over-expression) of EBF1. Chromatin immunoprecipitation assay revealed that EBF1 binds to proximal 5'-upstream regions around two putative EBF1 binding motifs of the gene in vivo. These results suggest that EBF1 takes part in transcriptional regulations of the Blimp-1 gene in immature B cells, and may play a key role in B cell differentiation. This is the first report on a novel EBF1 function in immature B cells as a powerful repressor of Blimp-1 gene expression.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22634309     DOI: 10.1016/j.bbrc.2012.05.099

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  7 in total

1.  Zinc finger-IRF composite elements bound by Ikaros/IRF4 complexes function as gene repression in plasma cell.

Authors:  Kyoko Ochiai; Haruka Kondo; Yasunobu Okamura; Hiroki Shima; Yuko Kurokochi; Kazumi Kimura; Ryo Funayama; Takeshi Nagashima; Keiko Nakayama; Katsuyuki Yui; Kengo Kinoshita; Kazuhiko Igarashi
Journal:  Blood Adv       Date:  2018-04-24

2.  Genetic dissection of TLR9 reveals complex regulatory and cryptic proinflammatory roles in mouse lupus.

Authors:  Claire Leibler; Shinu John; Rebecca A Elsner; Kayla B Thomas; Shuchi Smita; Stephen Joachim; Russell C Levack; Derrick J Callahan; Rachael A Gordon; Sheldon Bastacky; Ryutaro Fukui; Kensuke Miyake; Sebastien Gingras; Kevin M Nickerson; Mark J Shlomchik
Journal:  Nat Immunol       Date:  2022-09-23       Impact factor: 31.250

3.  GCN5 protects vertebrate cells against UV-irradiation via controlling gene expression of DNA polymerase η.

Authors:  Hidehiko Kikuchi; Futoshi Kuribayashi; Shinobu Imajoh-Ohmi; Hideki Nishitoh; Yasunari Takami; Tatsuo Nakayama
Journal:  J Biol Chem       Date:  2012-10-02       Impact factor: 5.157

4.  Epstein-Barr virus utilizes Ikaros in regulating its latent-lytic switch in B cells.

Authors:  Tawin Iempridee; Jessica A Reusch; Andrew Riching; Eric C Johannsen; Sinisa Dovat; Shannon C Kenney; Janet E Mertz
Journal:  J Virol       Date:  2014-02-12       Impact factor: 5.103

5.  A capture-sequencing strategy identifies IRF8, EBF1, and APRIL as novel IGH fusion partners in B-cell lymphoma.

Authors:  Hakim Bouamar; Saman Abbas; An-Ping Lin; Long Wang; Daifeng Jiang; Kenneth N Holder; Marsha C Kinney; Scott Hunicke-Smith; Ricardo C T Aguiar
Journal:  Blood       Date:  2013-06-17       Impact factor: 22.113

Review 6.  ZNF423 and ZNF521: EBF1 Antagonists of Potential Relevance in B-Lymphoid Malignancies.

Authors:  Maria Mesuraca; Emanuela Chiarella; Stefania Scicchitano; Bruna Codispoti; Marco Giordano; Giovanna Nappo; Heather M Bond; Giovanni Morrone
Journal:  Biomed Res Int       Date:  2015-12-16       Impact factor: 3.411

7.  Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.

Authors:  Napat Armartmuntree; Mariko Murata; Anchalee Techasen; Puangrat Yongvanit; Watcharin Loilome; Nisana Namwat; Chawalit Pairojkul; Chadamas Sakonsinsiri; Somchai Pinlaor; Raynoo Thanan
Journal:  Redox Biol       Date:  2017-11-13       Impact factor: 11.799

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.